U.S. Equities2h ago
Pfizer's Dividend Is Safe—And Cheap at 6.2% Yield
CEO Bourla and CFO Guegan made unambiguous commitments to maintaining and growing the dividend despite patent cliff risks, while the company's acquisition-driven growth portfolio is outpacing expectations.